Hyperlipidemia: Clinical Trials

2 trials for Hyperlipidemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Recruiting 2

Follow Hyperlipidemia: new trials by email Literature Review of Hyperlipidemia trials Research Report on Hyperlipidemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038)
Enlicitide Decanoate, Placebo - Hyperlipidemia, Hypercholesterolemia
Phase 3RecruitingMerck Sharp & Dohme LLC1502026-10-152026-11-02
A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
SHR-1918, SHR-1918 placebo - Hyperlipidemia
Phase 3RecruitingBeijing Suncadia Pharmaceuticals Co., Ltd9002026-01-132026-09-10

Narrower conditions

Hyperlipidemias (2)  ·  Hypercholesterolemia (1)

Broader conditions

Dyslipidemias (2)  ·  Lipid Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)

Interventions

MK-0616 (1)

Sponsors

Beijing Suncadia Pharmaceuticals Co., Ltd (1)  ·  Merck Sharp & Dohme LLC (1)

Countries

China (1)  ·  India (1)